{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:11:34Z","timestamp":1778267494961,"version":"3.51.4"},"reference-count":60,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"17","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.csbj.2014.08.001","type":"journal-article","created":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T23:47:18Z","timestamp":1407628038000},"page":"78-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity"],"prefix":"10.34133","volume":"10","author":[{"given":"Jinchun","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetoslav","family":"Slavov","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"Schnackenberg","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Greenhaw","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Salminen","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna L.","family":"Mendrick","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Beger","sequence":"additional","affiliation":[{"name":"Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2014,8,9]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep.23330","article-title":"Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation","volume":"51","author":"Fannin R.D.","year":"2010","unstructured":"Fannin R.D., Russo M., O'Connell T.M., Gerrish K., Winnike J.H., Macdonald J. et al: Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2010; 51: 227.","journal-title":"Hepatology"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/14740338.6.6.673","article-title":"Idiosyncratic drug-induced liver injury: an overview","volume":"6","author":"Hussaini S.H.","year":"2007","unstructured":"Hussaini S.H. and Farrington E.A.: Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 2007; 6: 673.","journal-title":"Expert Opin Drug Saf"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.658041"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archinte.1991.00400020036008","article-title":"Alanine aminotransferase in clinical practice. A review","volume":"151","author":"Sherman K.E.","year":"1991","unstructured":"Sherman K.E.: Alanine aminotransferase in clinical practice. A review. Arch Intern Med 1991; 151: 260.","journal-title":"Arch Intern Med"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fasebj.5.7.2010061","article-title":"Choline, an essential nutrient for humans","volume":"5","author":"Zeisel S.H.","year":"1991","unstructured":"Zeisel S.H., Da Costa K.A., Franklin P.D., Alexander E.A., Lamont J.T., Sheard N.F. et al: Choline, an essential nutrient for humans. FASEB J 1991; 5: 2093.","journal-title":"FASEB J"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/rtph.1998.1201","article-title":"Serum transaminase elevations as indicators of hepatic injury following the administration of drugs","volume":"27","author":"Amacher D.E.","year":"1998","unstructured":"Amacher D.E.: Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol 1998; 27: 119.","journal-title":"Regul Toxicol Pharmacol"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour D.R.","year":"2000","unstructured":"Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S. and Seeff L.B.: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46: 2050.","journal-title":"Clin Chem"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200124070-00001","article-title":"Drug-induced liver disorders: implications for drug development and regulation","volume":"24","author":"Kaplowitz N.","year":"2001","unstructured":"Kaplowitz N.: Drug-induced liver disorders: implications for drug development and regulation. Drug Saf 2001; 24: 483.","journal-title":"Drug Saf"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1750"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu J.J.","year":"2008","unstructured":"Xu J.J., Henstock P.V., Dunn M.C., Smith A.R., Chabot J.R. and de Graaf D.: Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 2008; 105: 97.","journal-title":"Toxicol Sci"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.11.021"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.108"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus C.L.","year":"2014","unstructured":"Bowlus C.L. and Gershwin M.E.: The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014; 13: 441.","journal-title":"Autoimmun Rev"},{"key":"e_1_3_2_15_2","volume-title":"Mechanisms of toxicity","author":"Gregus Z.","year":"2008","unstructured":"Gregus Z.: Mechanisms of toxicity. New York: McGraw Hill 2008."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.taap.2013.10.019","article-title":"Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan","volume":"274","author":"Jackson A.F.","year":"2013","unstructured":"Jackson A.F., Williams A., Recio L., Waters M.D., Lambert I.B. and Yauk C.L.: Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. Toxicol Appl Pharmacol 2013; 274: 63.","journal-title":"Toxicol Appl Pharmacol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.379"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.20215","article-title":"HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease","volume":"39","author":"Andrade R.J.","year":"2004","unstructured":"Andrade R.J., Lucena M.I., Alonso A., Garcia-Cortes M., Garcia-Ruiz E., Benitez R. et al: HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 2004; 39: 1603.","journal-title":"Hepatology"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/toxsci\/kfr321","article-title":"Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity","volume":"125","author":"Yang X.","year":"2012","unstructured":"Yang X., Greenhaw J., Shi Q., Su Z., Qian F., Davis K. et al: Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol Sci 2012; 125: 335.","journal-title":"Toxicol Sci"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2036.2011.04982.x","article-title":"Serum proteomic profiling in patients with drug-induced liver injury","volume":"35","author":"Bell L.N.","year":"2012","unstructured":"Bell L.N., Vuppalanchi R., Watkins P.B., Bonkovsky H.L., Serrano J., Fontana R.J. et al: Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther 2012; 35: 600.","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.23271","article-title":"Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease","volume":"51","author":"Bell L.N.","year":"2010","unstructured":"Bell L.N., Theodorakis J.L., Vuppalanchi R., Saxena R., Bemis K.G., Wang M. et al: Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology 2010; 51: 111.","journal-title":"Hepatology"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2014.07.021","article-title":"Detection of hepatotoxicity potential with metabolite (metabolomics) profiling of rat plasma","author":"Mattes W.","year":"2014","unstructured":"Mattes W., Davis K., Fabian E., Greenhaw J., Herold M., Looser R. et al: Detection of hepatotoxicity potential with metabolite (metabolomics) profiling of rat plasma. Toxicol Lett 2014; . S0378-4274.","journal-title":"Toxicol Lett"},{"key":"e_1_3_2_23_2","first-page":"S1","article-title":"Systems biology investigation to discover metabolic biomarkers of acetaminophen-induced hepatic injury using integrated transcriptomics and metabolomics","author":"Sun J.","year":"2013","unstructured":"Sun J., Ando Y., Ahlbory-Dieker D., Schnackenberg L.K., Yang X., Greenhaw J. et al: Systems biology investigation to discover metabolic biomarkers of acetaminophen-induced hepatic injury using integrated transcriptomics and metabolomics. J Mol. Biomark. Diagn. 2013; : S1.","journal-title":"J Mol. Biomark. Diagn."},{"key":"e_1_3_2_24_2","article-title":"Comprehensive analysis of alterations in lipid and bile acid metabolism by carbon tetrachloride using integrated transcriptomics and metabolomics","author":"Sun J.","year":"2014","unstructured":"Sun J., Schmitt T., Schnackenberg L.K., Pence L., Ando Y., Greenhaw J. et al: Comprehensive analysis of alterations in lipid and bile acid metabolism by carbon tetrachloride using integrated transcriptomics and metabolomics. Metabolomics 2014; . [Epub. ahead of print].","journal-title":"Metabolomics"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jchromb.2013.05.030","article-title":"Evaluating effects of penicillin treatment on the metabolome of rats","volume":"932","author":"Sun J.","year":"2013","unstructured":"Sun J., Schnackenberg L.K., Khare S., Yang X., Greenhaw J., Salminen W. et al: Evaluating effects of penicillin treatment on the metabolome of rats. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 932: 134.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell R.G.","year":"1981","unstructured":"Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N. et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431.","journal-title":"Hepatology"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4155\/bio.09.173","article-title":"Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics","volume":"2","author":"Sun J.","year":"2010","unstructured":"Sun J., Schnackenberg L.K., Hansen D.K. and Beger R.D.: Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics. Bioanalysis 2010; 2: 207.","journal-title":"Bioanalysis"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.jchromb.2009.06.033","article-title":"Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC\/MS-based metabonomics analysis","volume":"877","author":"Sun J.","year":"2009","unstructured":"Sun J., Von Tungeln L.S., Hines W. and Beger R.D.: Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC\/MS-based metabonomics analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 2557.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.1976.03270170040024","article-title":"Fatal massive hepatic necrosis following acetaminophen overdose","volume":"236","author":"McJunkin B.","year":"1976","unstructured":"McJunkin B., Barwick K.W., Little W.C. and Winfield J.B.: Fatal massive hepatic necrosis following acetaminophen overdose. JAMA 1976; 236: 1874.","journal-title":"JAMA"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0168-8278(98)80361-9","article-title":"Severe idiosyncratic acute hepatic injury caused by paracetamol","volume":"28","author":"Andrade R.J.","year":"1998","unstructured":"Andrade R.J., Lucena M.I., Garcia-Escano M.D. and Camargo R.: Severe idiosyncratic acute hepatic injury caused by paracetamol. J Hepatol 1998; 28: 1078.","journal-title":"J Hepatol"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12272-013-0110-x","article-title":"Hepatoprotective effect of methylsulfonylmethane against carbon tetrachloride-induced acute liver injury in rats","volume":"36","author":"Kamel R.","year":"2013","unstructured":"Kamel R. and El Morsy E.M.: Hepatoprotective effect of methylsulfonylmethane against carbon tetrachloride-induced acute liver injury in rats. Arch Pharm Res 2013; 36: 1140.","journal-title":"Arch Pharm Res"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-2797(02)00057-1","article-title":"Mechanisms of idiosyncratic drug reactions: the case of felbamate","volume":"142","author":"Dieckhaus C.M.","year":"2002","unstructured":"Dieckhaus C.M., Thompson C.D., Roller S.G. and Macdonald T.L.: Mechanisms of idiosyncratic drug reactions: the case of felbamate. Chem Biol Interact 2002; 142: 99.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","article-title":"Dantrolene-associated hepatic injury. Incidence and character","volume":"72","author":"Utili R.","year":"1977","unstructured":"Utili R., Boitnott J.K. and Zimmerman H.J.: Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology 1977; 72: 610.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_34_2","unstructured":"Shapiro B. and Ruff R.: Disorders of skeletal muscle membrane excitability: myotonia congenita paramyotonia congenita periodic paralysis and related disorders. In: . : Butterworth-Heinemann 2002."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/BF02208681","article-title":"Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens","volume":"40","author":"Santucci L.","year":"1995","unstructured":"Santucci L., Fiorucci S., Patoia L., Di Matteo F.M., Brunori P.M. and Morelli A.: Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci 1995; 40: 2074.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-013-8367-x","article-title":"Diagnosis and management of immediate hypersensitivity reactions to cephalosporins","volume":"45","author":"Dickson S.D.","year":"2013","unstructured":"Dickson S.D. and Salazar K.C.: Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Clin Rev Allergy Immunol 2013; 45: 131.","journal-title":"Clin Rev Allergy Immunol"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2337\/dc11-2306","article-title":"Metformin-induced hepatotoxicity","volume":"35","author":"Miralles-Linares F.","year":"2012","unstructured":"Miralles-Linares F., Puerta-Fernandez S., Bernal-Lopez M.R., Tinahones F.J., Andrade R.J. and Gomez-Huelgas R.: Metformin-induced hepatotoxicity. Diabetes Care 2012; 35: e21.","journal-title":"Diabetes Care"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881201)62:11<2287::AID-CNCR2820621103>3.0.CO;2-H"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour D.R.","year":"2000","unstructured":"Dufour D.R., Lott J.A., Nolte F.S., Gretch D.R., Koff R.S. and Seeff L.B.: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46: 2050.","journal-title":"Clin Chem"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins P.B.","year":"1994","unstructured":"Watkins P.B., Zimmerman H.J., Knapp M.J., Gracon S.I. and Lewis K.W.: Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271: 992.","journal-title":"JAMA"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1750"},{"key":"e_1_3_2_42_2","first-page":"42","volume-title":"Accelerating the development of biomarkers for drug safety","author":"Olson S.","year":"2009","unstructured":"Olson S., Robinson S. and Giffin R.: Accelerating the development of biomarkers for drug safety. : 2009: 42."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"202497","DOI":"10.1155\/2013\/202497","article-title":"Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling","volume":"2013","author":"Mattes W.B.","year":"2013","unstructured":"Mattes W.B., Kamp H.G., Fabian E., Herold M., Krennrich G., Looser R. et al: Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling. Biomed. Res. Int. 2013; 2013: 202497.","journal-title":"Biomed. Res. Int."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201000512"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx800464q","article-title":"Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity","volume":"22","author":"Chen C.","year":"2009","unstructured":"Chen C., Krausz K.W., Shah Y.M., Idle J.R. and Gonzalez F.J.: Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol 2009; 22: 699.","journal-title":"Chem Res Toxicol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/bmm.13.150","article-title":"Targeted liquid chromatography\u2013mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children","volume":"8","author":"Bhattacharyya S.","year":"2014","unstructured":"Bhattacharyya S., Yan K., Pence L., Simpson P.M., Gill P., Letzig L.G. et al: Targeted liquid chromatography\u2013mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children. Biomark Med 2014; 8: 147.","journal-title":"Biomark Med"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/dmd.104.001735","article-title":"Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4","volume":"33","author":"Kalgutkar A.S.","year":"2005","unstructured":"Kalgutkar A.S., Vaz A.D., Lame M.E., Henne K.R., Soglia J., Zhao S.X. et al: Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab Dispos 2005; 33: 243.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.3.0015"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.108.026195","article-title":"Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure","volume":"37","author":"James L.P.","year":"2009","unstructured":"James L.P., Letzig L., Simpson P.M., Capparelli E., Roberts D.W., Hinson J.A. et al: Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009; 37: 1779.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1016\/S0021-9258(19)67754-9","article-title":"Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes","volume":"266","author":"Burcham P.C.","year":"1991","unstructured":"Burcham P.C. and Harman A.W.: Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J Biol Chem 1991; 266: 5049.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M701742200"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0009-2797(02)00058-3","article-title":"Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro","volume":"142","author":"Kapetanovic I.M.","year":"2002","unstructured":"Kapetanovic I.M., Torchin C.D., Strong J.M., Yonekawa W.D., Lu C., Li A.P. et al: Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro. Chem Biol Interact 2002; 142: 119.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_2_53_2","first-page":"381","article-title":"Dantrolene sodium: urinary metabolites and hepatotoxicity","volume":"39","author":"Arnold T.H.","year":"1983","unstructured":"Arnold T.H., Epps J.M., Cook H.R. and Hamrick M.E.: Dantrolene sodium: urinary metabolites and hepatotoxicity. Res Commun Chem Pathol Pharmacol 1983; 39: 381.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx200168d"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.379"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2728(98)00112-1"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.taap.2012.08.015","article-title":"Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity","volume":"264","author":"McGill M.R.","year":"2012","unstructured":"McGill M.R., Williams C.D., Xie Y., Ramachandran A. and Jaeschke H.: Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 2012; 264: 387.","journal-title":"Toxicol Appl Pharmacol"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s12272-011-1108-x","article-title":"Assessment of reactive metabolites in drug-induced liver injury","volume":"34","author":"Lee K.S.","year":"2011","unstructured":"Lee K.S., Oh S.J., Kim H.M., Lee K.H. and Kim S.K.: Assessment of reactive metabolites in drug-induced liver injury. Arch Pharm Res 2011; 34: 1879.","journal-title":"Arch Pharm Res"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.111.187948","article-title":"Changes in mouse liver protein glutathionylation after acetaminophen exposure","volume":"340","author":"Yang X.","year":"2012","unstructured":"Yang X., Greenhaw J., Ali A., Shi Q., Roberts D.W., Hinson J.A. et al: Changes in mouse liver protein glutathionylation after acetaminophen exposure. J Pharmacol Exp Ther 2012; 340: 360.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.bi.57.070188.000333","article-title":"DNA repair enzymes","volume":"57","author":"Sancar A.","year":"1988","unstructured":"Sancar A. and Sancar G.B.: DNA repair enzymes. Annu Rev Biochem 1988; 57: 29.","journal-title":"Annu Rev Biochem"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00084.2006"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037014000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037014000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2014.08.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:01:48Z","timestamp":1778266908000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2014.08.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":60,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1016\/j.csbj.2014.08.001"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2014.08.001","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2014.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}